Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick, Theo Ruers, Daniela E Aust, et al.
BMC Cancer
|
April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks
Heiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
Molecular Cancer
|
July 22, 2025
An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial
Anton Lahusen, Manfred P Lutz, Rui Fang, et al.
Annals of Surgery
|
February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)
Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2020
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD
Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, et al.
British Journal of Cancer
|
October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)
Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group
Manfred P Lutz, Eric Van Cutsem, Theo Wagener, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma
Manfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick, Theo Ruers, Daniela E Aust, et al.
BMC Cancer
|
April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks
Heiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
Molecular Cancer
|
July 22, 2025
An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial
Anton Lahusen, Manfred P Lutz, Rui Fang, et al.
Annals of Surgery
|
February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)
Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2020
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD
Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, et al.
British Journal of Cancer
|
October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)
Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group
Manfred P Lutz, Eric Van Cutsem, Theo Wagener, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma
Manfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Page
of 4